Page last updated: 2024-09-03

esonarimod and Disease Models, Animal

esonarimod has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV	1
Higaki, M; Inoue, T; Yamashita, M	1

Other Studies

2 other study(ies) available for esonarimod and Disease Models, Animal

Article	Year
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49 Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection	2020
The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1beta-stimulated synoviocytes of patients with rheumatoid arthritis. Rheumatology international, 2001, Volume: 20, Issue:4 Topics: Aged; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Base Sequence; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Disease Models, Animal; Electrophoresis; Female; Humans; Interleukin-1; Male; Middle Aged; Molecular Sequence Data; Phenylpropionates; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Synovial Membrane	2001

Article

Year

Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.

Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020

The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1beta-stimulated synoviocytes of patients with rheumatoid arthritis.

Rheumatology international, 2001, Volume: 20, Issue:4

Topics: Aged; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Base Sequence; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Disease Models, Animal; Electrophoresis; Female; Humans; Interleukin-1; Male; Middle Aged; Molecular Sequence Data; Phenylpropionates; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Synovial Membrane

2001